Pulse Biosciences is a bioelectric medicine company developing its proprietary CellFX nsPFA technology to non-thermally ablate tissue for treating atrial fibrillation and other conditions. The company fosters a creative, collaborative, startup-like culture focused on innovation and professional growth.